Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
|
|
IONIS PHARMACEUTICALS INC (IONS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
4
| BENNETT C FRANK (EVP, Chief Scientific Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Sold 4,460 shares
@ $46.5, valued at
$207.4k
|
|
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2023 |
4
| Diaz Allene M. (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Sold 657 shares
@ $41.05, valued at
$27k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2023 |
4
| WENDER JOSEPH H (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| KLEIN JOSEPH III (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| HERMAN JOAN E (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| Hayden Michael R (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| Diaz Allene M. (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| BERTHELSEN SPENCER R (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 05/24/2023 |
4
| O'NEIL PATRICK R. (EVP CLO & General Counsel) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Sold 1,527 shares
@ $41.7, valued at
$63.7k
|
|
| 05/24/2023 |
4
| Monia Brett P (CEO) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Sold 2,301 shares
@ $40.13, valued at
$92.3k
Sold 2,630 shares
@ $40.14, valued at
$105.6k
|
|
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2023 |
4
| Swayze Eric (EVP Research) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Acquired 575 shares
@ $30.515, valued at
$17.5k
|
|
| 03/02/2023 |
4
| O'NEIL PATRICK R. (EVP CLO & General Counsel) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Acquired 301 shares
@ $30.515, valued at
$9.2k
|
|
| 03/02/2023 |
4
| Geary Richard S (EVP, Chief Development Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Acquired 575 shares
@ $30.515, valued at
$17.5k
|
|
| 03/02/2023 |
4
| HOUGEN ELIZABETH L (EVP, Finance & CFO) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Acquired 163 shares
@ $30.515, valued at
$5k
|
|
| 03/02/2023 |
4
| BENNETT C FRANK (EVP, Chief Scientific Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Acquired 383 shares
@ $30.515, valued at
$11.7k
|
|
| 02/07/2023 |
4
| Swayze Eric (EVP Research) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 3,715 shares
@ $0
Sold 1,815 shares
@ $40.7886, valued at
$74k
|
|
| 02/07/2023 |
4
| Schneider Eugene (EVP, Chf Clinical Develop Ofcr) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 4,033 shares
@ $0
Sold 1,413 shares
@ $40.6682, valued at
$57.5k
|
|
| 02/07/2023 |
4
| O'NEIL PATRICK R. (EVP CLO & General Counsel) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 3,822 shares
@ $0
Sold 1,920 shares
@ $40.8648, valued at
$78.5k
|
|
|
|
|